These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38358804)

  • 1. Cathepsin B-Responsive Programmed Brain Targeted Delivery System for Chemo-Immunotherapy Combination Therapy of Glioblastoma.
    Jiang S; Li W; Yang J; Zhang T; Zhang Y; Xu L; Hu B; Li Z; Gao H; Huang Y; Ruan S
    ACS Nano; 2024 Feb; 18(8):6445-6462. PubMed ID: 38358804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted reprogramming of tumor-associated macrophages for overcoming glioblastoma resistance to chemotherapy and immunotherapy.
    Li J; Yang J; Jiang S; Tian Y; Zhang Y; Xu L; Hu B; Shi H; Li Z; Ran G; Huang Y; Ruan S
    Biomaterials; 2024 Dec; 311():122708. PubMed ID: 39047538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTN-PTPRZ1 signaling axis blocking mediates tumor microenvironment remodeling for enhanced glioblastoma treatment.
    Yang M; Wang B; Yin Y; Ma X; Tang L; Zhang Y; Fan Q; Yin T; Wang Y
    J Control Release; 2023 Jan; 353():63-76. PubMed ID: 36402232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimuli-Responsive Multifunctional Nanomedicine for Enhanced Glioblastoma Chemotherapy Augments Multistage Blood-to-Brain Trafficking and Tumor Targeting.
    Martins C; Araújo M; Malfanti A; Pacheco C; Smith SJ; Ucakar B; Rahman R; Aylott JW; Préat V; Sarmento B
    Small; 2023 Jun; 19(22):e2300029. PubMed ID: 36852650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Harnessing the cross-talk between tumor cells and tumor-associated macrophages with a nano-drug for modulation of glioblastoma immune microenvironment.
    Li TF; Li K; Wang C; Liu X; Wen Y; Xu YH; Zhang Q; Zhao QY; Shao M; Li YZ; Han M; Komatsu N; Zhao L; Chen X
    J Control Release; 2017 Dec; 268():128-146. PubMed ID: 29051064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Trojan-Horse-Like Biomimetic Nano-NK to Elicit an Immunostimulatory Tumor Microenvironment for Enhanced GBM Chemo-Immunotherapy.
    Zhang L; Zhang Y; Wang X; Zhou Y; Qi J; Gu L; Zhao Q; Yu R; Zhou X
    Small; 2023 Nov; 19(44):e2301439. PubMed ID: 37420326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-Density Lipoprotein-Mimicking Nanodiscs for Chemo-immunotherapy against Glioblastoma Multiforme.
    Kadiyala P; Li D; Nuñez FM; Altshuler D; Doherty R; Kuai R; Yu M; Kamran N; Edwards M; Moon JJ; Lowenstein PR; Castro MG; Schwendeman A
    ACS Nano; 2019 Feb; 13(2):1365-1384. PubMed ID: 30721028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCR4-targeted nitric oxide nanoparticles deliver PD-L1 siRNA for immunotherapy against glioblastoma.
    Hsieh HT; Huang HC; Chung CW; Chiang CC; Hsia T; Wu HF; Huang RL; Chiang CS; Wang J; Lu TT; Chen Y
    J Control Release; 2022 Dec; 352():920-930. PubMed ID: 36334859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retro-inverso isomer of Angiopep-2: a stable d-peptide ligand inspires brain-targeted drug delivery.
    Wei X; Zhan C; Chen X; Hou J; Xie C; Lu W
    Mol Pharm; 2014 Oct; 11(10):3261-8. PubMed ID: 24673510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of hyaluronic acid conjugates with immunogenic cell death inducer and CpG for glioblastoma local chemo-immunotherapy elicits an immune response and induces long-term survival.
    Catania G; Rodella G; Vanvarenberg K; Préat V; Malfanti A
    Biomaterials; 2023 Mar; 294():122006. PubMed ID: 36701998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of Therapies for Glioblastoma (GBM) Using Nanoparticle-based Delivery Systems.
    Wiwatchaitawee K; Quarterman JC; Geary SM; Salem AK
    AAPS PharmSciTech; 2021 Feb; 22(2):71. PubMed ID: 33575970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted nano-delivery of chemotherapy via intranasal route suppresses in vivo glioblastoma growth and prolongs survival in the intracranial mouse model.
    Sandbhor P; Goda J; Mohanty B; Gera P; Yadav S; Chekuri G; Chaudhari P; Dutt S; Banerjee R
    Drug Deliv Transl Res; 2023 Feb; 13(2):608-626. PubMed ID: 36245060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunostimulant In Situ Fibrin Gel for Post-operative Glioblastoma Treatment by Macrophage Reprogramming and Photo-Chemo-Immunotherapy.
    Zhang R; Ye Y; Wu J; Gao J; Huang W; Qin H; Tian H; Han M; Zhao B; Sun Z; Chen X; Dong X; Liu K; Liu C; Tu Y; Zhao S
    ACS Appl Mater Interfaces; 2023 Apr; 15(14):17627-17640. PubMed ID: 37000897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting glioblastoma through nano- and micro-particle-mediated immune modulation.
    Poot E; Maguregui A; Brunton VG; Sieger D; Hulme AN
    Bioorg Med Chem; 2022 Oct; 72():116913. PubMed ID: 36007293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The N
    Zhao R; Li B; Zhang S; He Z; Pan Z; Guo Q; Qiu W; Qi Y; Zhao S; Wang S; Chen Z; Zhang P; Guo X; Xue H; Li G
    Front Immunol; 2021; 12():653711. PubMed ID: 34354698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elucidating tumour-associated microglia/macrophage diversity along glioblastoma progression and under ACOD1 deficiency.
    Pires-Afonso Y; Muller A; Grzyb K; Oudin A; Yabo YA; Sousa C; Scafidi A; Poli A; Cosma A; Halder R; Coowar D; Golebiewska A; Skupin A; Niclou SP; Michelucci A
    Mol Oncol; 2022 Sep; 16(17):3167-3191. PubMed ID: 35838338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophages and microglia in glioblastoma: heterogeneity, plasticity, and therapy.
    Khan F; Pang L; Dunterman M; Lesniak MS; Heimberger AB; Chen P
    J Clin Invest; 2023 Jan; 133(1):. PubMed ID: 36594466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-140 targeting CTSB signaling suppresses the mesenchymal transition and enhances temozolomide cytotoxicity in glioblastoma multiforme.
    Ho KH; Cheng CH; Chou CM; Chen PH; Liu AJ; Lin CW; Shih CM; Chen KC
    Pharmacol Res; 2019 Sep; 147():104390. PubMed ID: 31398406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transferrin receptors-targeting nanocarriers for efficient targeted delivery and transcytosis of drugs into the brain tumors: a review of recent advancements and emerging trends.
    Choudhury H; Pandey M; Chin PX; Phang YL; Cheah JY; Ooi SC; Mak KK; Pichika MR; Kesharwani P; Hussain Z; Gorain B
    Drug Deliv Transl Res; 2018 Oct; 8(5):1545-1563. PubMed ID: 29916012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application prospect of peptide-modified nano targeting drug delivery system combined with PD-1/PD-L1 based immune checkpoint blockade in glioblastoma.
    Song P; Zhao X; Xiao S
    Int J Pharm; 2020 Nov; 589():119865. PubMed ID: 32919004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.